Innovation in Oncology Diagnostics – a sound investment opportunity
Arquer Diagnostics is leading the way in non-invasive tests for diagnosing and monitoring cancer. We have exciting clinical trial data from our products for bladder, prostate and endometrial cancers, and also have the capability and technology to investigate other indications. As we plan our expansion and US market entry, we are looking for a small number of additional investors to share our vision to create transformational change in oncology diagnostics.
The simplicity of our patented technology is its biggest strength. Our tests are accurate, reliable, cost-effective, and can be used universally. We have strong advisory boards – every step we take is guided by clinicians, putting patient’s needs at the forefront of our decision-making. We have a first-class team of dedicated people who have proved they can deliver across R&D, product development, our rigorous clinical programmes and robust manufacturing through to distribution and marketing.
If you’re interested in joining us on our journey, please contact me to find out more by completing this form or calling me on +44 (0) 191 516 6765
Nadia Whittley, CEO